Al-Batran SE - Search Results

1

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.

Hegewisch-Becker S, Graeven U, Lerchenmüller CA, Killing B, Depenbusch R, Steffens CC, Al-Batran SE, Lange T, Dietrich G, Stoehlmacher J, Tannapfel A, Reinacher-Schick A, Quidde J, Trarbach T, Hinke A, Schmoll HJ, Arnold D. Hegewisch-Becker S, et al. Lancet Oncol. 2015 Oct;16(13):1355-69. doi: 10.1016/S1470-2045(15)00042-X. Epub 2015 Sep 8. Lancet Oncol. 2015. PMID: 26361971 Clinical Trial.

2

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

Al-Batran SE, Atmaca A, Hegewisch-Becker S, Jaeger D, Hahnfeld S, Rummel MJ, Seipelt G, Rost A, Orth J, Knuth A, Jaeger E. Al-Batran SE, et al. J Clin Oncol. 2004 Feb 15;22(4):658-63. doi: 10.1200/JCO.2004.07.042. J Clin Oncol. 2004. PMID: 14966088 Clinical Trial.

3

Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 cases.

Wolschke C, Goekkurt E, Al-Batran SE, Hossfeld DK, Stoehlmacher J. Wolschke C, et al. Onkologie. 2005 Nov;28(11):589-92. doi: 10.1159/000088916. Onkologie. 2005. PMID: 16249645

4

Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.

Al-Batran SE, Kerber A, Atmaca A, Dechow C, Reitsamer E, Schmidt S, Kolassa Y, Neumann A, Weidmann E, Hartmann JT, Jäger E. Al-Batran SE, et al. Onkologie. 2007 Feb;30(1-2):29-34. doi: 10.1159/000097768. Epub 2007 Jan 26. Onkologie. 2007. PMID: 17264523 Clinical Trial.

5

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.

Al-Batran SE, Hartmann JT, Heidel F, Stoehlmacher J, Wardelmann E, Dechow C, Düx M, Izbicki JR, Kraus T, Fischer T, Jäger E. Al-Batran SE, et al. Gastric Cancer. 2007;10(3):145-52. doi: 10.1007/s10120-007-0425-8. Epub 2007 Sep 26. Gastric Cancer. 2007. PMID: 17922091

6

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.

Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E; Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE, et al. J Clin Oncol. 2008 Mar 20;26(9):1435-42. doi: 10.1200/JCO.2007.13.9378. J Clin Oncol. 2008. PMID: 18349393 Clinical Trial.

7

[Treatment of gastric cancer].

Lordick F, Ridwelski K, Al-Batran SE, Trarbach T, Schlag PM, Piso P. Lordick F, et al. Onkologie. 2008;31 Suppl 5:32-9. doi: 10.1159/000163075. Epub 2008 Nov 14. Onkologie. 2008. PMID: 19033703 Review. German.

8

Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

Goekkurt E, Al-Batran SE, Hartmann JT, Mogck U, Schuch G, Kramer M, Jaeger E, Bokemeyer C, Ehninger G, Stoehlmacher J. Goekkurt E, et al. J Clin Oncol. 2009 Jun 10;27(17):2863-73. doi: 10.1200/JCO.2008.19.1718. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332728

9

Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer.

Atmaca A, Pauligk C, Steinmetz K, Altmannsberger HM, Jäger E, Al-Batran SE. Atmaca A, et al. Oncology. 2011;80(1-2):130-4. doi: 10.1159/000329063. Epub 2011 Jun 14. Oncology. 2011. PMID: 21677458

10

Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.

Al-Batran SE, Hozaeel W, Jäger E. Al-Batran SE, et al. Onkologie. 2012;35(9):505-8. doi: 10.1159/000341841. Epub 2012 Aug 17. Onkologie. 2012. PMID: 23007148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters